About Us

Mission Statement

CleveX™, Inc. is committed to advancing dermatological technology. Our novel technologies in skin biopsy, wound closure and repair - significantly improve patient outcomes and enhance practice economics - enabling physicians and health care providers to accelerate the diagnosis and treatment of skin diseases and cancers.

Vision of Founders

CleveX™ founders set out to establish better ways to manage skin excisions and biopsies. The founders wanted patients to experience less trauma and significantly better healing than was delivered with a surgical suture approach. They determined to enhance the clinical aspects, saving significant procedural time while delivering attractive margins for the professional practice. CleveX™ found these physicians to be hungry for technology innovations, new products and new procedures.

History

CleveX™, Inc., was founded in 2003 to commercialize novel technologies conceived by Plastic Surgeons and Dermatologists at the Cleveland Clinic Foundation (CCF). CCF  Innovations, the commercialization arm of CCF, partnered with IDx Medical, a surgical instrument “accelerator” in Cincinnati, OH, to complete the design and development of the ExiClip™ - the Company’s flagship product. CleveX™, Inc., was established in late 2006 when the Company raised Series A funding to accelerate commercial entry. Today, CleveX™ has 510(k) clearance to market and sell the ExiClip™ and its accessories. The company's corporate headquarters are in Columbus, Ohio.